2327 related articles for article (PubMed ID: 8866244)
1. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
3. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
[TBL] [Abstract][Full Text] [Related]
4. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
5. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
[TBL] [Abstract][Full Text] [Related]
6. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity.
Spiga F; Harrison LR; Wood S; Knight DM; MacSweeney CP; Thomson F; Craighead M; Lightman SL
J Endocrinol; 2009 Mar; 200(3):273-83. PubMed ID: 19008333
[TBL] [Abstract][Full Text] [Related]
8. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
Zelena D; Mergl Z; Makara GB
Brain Res; 2005 Jan; 1031(2):185-93. PubMed ID: 15649443
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
[TBL] [Abstract][Full Text] [Related]
10. The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamie-pituitary-adrenal response during crowding stress.
Bugajski AJ; Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2006 Sep; 57(3):463-77. PubMed ID: 17033098
[TBL] [Abstract][Full Text] [Related]
11. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
[TBL] [Abstract][Full Text] [Related]
12. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
13. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
14. Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat.
Calogero AE; Kamilaris TC; Bernardini R; Johnson EO; Chrousos GP; Gold PW
J Pharmacol Exp Ther; 1990 May; 253(2):729-37. PubMed ID: 2160009
[TBL] [Abstract][Full Text] [Related]
15. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions.
Bugajski J; Gadek-Michalska A; Ołowska A; Borycz J; Głód R; Bugajski AJ
J Physiol Pharmacol; 1995 Sep; 46(3):297-312. PubMed ID: 8527811
[TBL] [Abstract][Full Text] [Related]
17. Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity.
Gadek-Michalska A; Bugajski J; Bugajski AJ; Głód R
J Physiol Pharmacol; 2002 Jun; 53(2):275-87. PubMed ID: 12120902
[TBL] [Abstract][Full Text] [Related]
18. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
[TBL] [Abstract][Full Text] [Related]
19. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.
Heiman ML; Ahima RS; Craft LS; Schoner B; Stephens TW; Flier JS
Endocrinology; 1997 Sep; 138(9):3859-63. PubMed ID: 9275075
[TBL] [Abstract][Full Text] [Related]
20. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
